Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells  Marie Bleakley,

Slides:



Advertisements
Similar presentations
Reduced Frequency of Regulatory T Cells in Peripheral Blood Stem Cell Compared to Bone Marrow Transplantations  Céline Blache, Joe-Marc Chauvin, Aude.
Advertisements

Volume 122, Issue 5, Pages (May 2002)
Volume 19, Issue 12, Pages (December 2011)
Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses by Giulia Nizzoli, Jana Krietsch, Anja Weick, Svenja.
Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications.
Krystel Vincent, Marie-Pierre Hardy, Assya Trofimov, Céline M
CMV-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome  Cinja Sukdolak,
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
Promiscuity of the AlloHLA-A2 Restricted T Cell Repertoire Hampers the Generation of Minor Histocompatibility Antigen-specific Cytotoxic T Cells across.
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Volume 31, Issue 5, Pages (November 2009)
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.
In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial  Divya T. Koura, John T.
Altered Homeostasis of CD4+ Memory T Cells in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Chronic Graft-versus-Host Disease Enhances T Cell.
Volume 143, Issue 4, Pages e9 (October 2012)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
Molecular Therapy - Nucleic Acids
Effects of the NK Cell Recovery on Outcomes of Unmanipulated Haploidentical Blood and Marrow Transplantation for Patients with Hematologic Malignancies 
Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells  Allan D. Hess,
Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell–depleted stem cell transplantation.
Skin-Resident Effector Memory CD8+CD28– T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis  Gang Li, Adriana T. Larregina, Robyn.
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia  Guenther.
Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo by Suzanne M. McGoldrick, Marie E. Bleakley,
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses by Cagan Gurer, Till.
Activation and Expansion of CD8+ T Effector Cells in Patients with Chronic Graft- versus-Host Disease  Bryan M. Grogan, Laura Tabellini, Barry Storer,
Growth and Differentiation Advantages of CD4+OX40+ T Cells from Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takero Shindo, Takayuki.
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
R. Handgretinger, X. Chen, M. Pfeiffer, M. Schumm, I. Mueller, T
Volume 17, Issue 9, Pages (September 2009)
Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor.
Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach  Jeremiah.
Volume 138, Issue 4, Pages (April 2010)
Long-Term Immune Reconstitution of Naive and Memory T Cell Pools after Haploidentical Hematopoietic Stem Cell Transplantation  Rita I. Azevedo, Maria.
Volume 143, Issue 6, Pages e4 (December 2012)
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome  Caroline Pical-Izard, Roberto.
Volume 38, Issue 2, Pages (February 2013)
J. Joseph Melenhorst, Phillip Scheinberg, Ann Williams, David R
Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells after Haploidentical Stem Cell Transplantation  Siok-Keen Tey, Gianpietro.
Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods  Steven A. Dezell,
Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation 
Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets.
Volume 48, Issue 1, Pages e5 (January 2018)
Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell–engrafted NOD/SCID/IL-2Rγcnull mice  Simone Thomas,
Lisa A. Palmer, George E. Sale, John I
Recombinant Human Granulocyte Colony-Stimulating Factor Significantly Decreases the Expression of CXCR3 and CCR6 on T Cells and Preferentially Induces.
Volume 19, Issue 11, Pages (November 2011)
Volume 31, Issue 5, Pages (November 2009)
Consistent Collection and Processing of Non-Mobilized Mononuclear Cell, Apheresis Products from HLA Haploidentical Bone Marrow Donors for Sequential CD3+
A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2−
Volume 76, Issue 5, Pages (September 2009)
David J. Chung, MD, PhD, Katherine B. Pronschinske, Justin A
Eva Guinan, Leo Luzmik, Rupert Handgretinger, Ann Woolfrey 
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 13, Issue 2, Pages (February 2006)
Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease 
Expansion of cytolytic CD4+CD28− T cells in end-stage renal disease
Volume 29, Issue 4, Pages (October 2008)
Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses  Julia A. Wagner, Melissa.
Donor and recipient BAL T cells are phenotypically and functionally memory T cells. Donor and recipient BAL T cells are phenotypically and functionally.
CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study  Fabien.
Marta E. Polak, Louise Newell, Vadim Y
Early Recovery of CD4 T Cell Receptor Diversity after “Lymphoablative” Conditioning and Autologous CD34 Cell Transplantation  Jan Storek, Zhao Zhao, Yiping.
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation  Abir Bhattacharyya, Laïla-Aïcha.
Mary Eapen  Biology of Blood and Marrow Transplantation 
Correlation of Infused CD3+CD8+ Cells with Single-Donor Dominance after Double-Unit Cord Blood Transplantation  Filippo Milano, Shelly Heimfeld, Ted Gooley,
Graft Monocytic Myeloid-Derived Suppressor Cell Content Predicts the Risk of Acute Graft-versus-Host Disease after Allogeneic Transplantation of Granulocyte.
Presentation transcript:

Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells  Marie Bleakley, Shelly Heimfeld, Lori A. Jones, Cameron Turtle, Diane Krause, Stanley R. Riddell, Warren Shlomchik  Biology of Blood and Marrow Transplantation  Volume 20, Issue 5, Pages 705-716 (May 2014) DOI: 10.1016/j.bbmt.2014.01.032 Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Flow cytometric analysis of normal donor blood cells. Blood cells obtained from normal donors were analyzed by flow cytometry to assist in designing of a cell selection strategy to deplete TN from G-PBSC. (A) Stability of CD62L and CD45RA expression on CD4+ or CD8+ T cells in G-PBSC at 2 and 24 hours after apheresis collection (live CD3+ lymphocyte gate). (B) Expression of CD45RA and CD45RO on CD3+, CD4+, and CD8+ T cells in normal donors with the typical (panels 1 and 2) and variant patterns of CD45 expression (panels 3 and 4). Data is shown after gating on live lymphocytes. (C) CD45RA is expressed on a minor subset of CD34+ cells in samples of normal donor PBMC, or CD34+ cells isolated by positive immunomagnetic selection from G-PBSC. Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Cell selection procedure. The flow diagram depicts the cell processing procedure to deplete TN from G-PBSC, preserve CD34+ stem cells and deliver a fixed dose of TM cells. Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Results of cell selection procedures. (A) TN (CD45RA+CD45RO−CD3+) content of (CD34-depleted) G-PBSC product, CD45RA-depleted fraction, and CD45RA+ fraction from cell selection on G-PBSC from a representative donor (gated on live CD3+ T cells). (B) CD3+ TN content in the initial G-PBSC and in an aliquot prepared for infusion after depletion of CD45RA+ cells on 15 representative donors after adjusting the CD3+ TM content in the CD45RA− fraction to 107 cells/kg. (C) Total CD34+ cell content and (D) CD3+ and TN CD3+CD45RA+ content of the infused cell products. (E) TN (CD3+CD45RA+) content in the CD34+ fraction and in the CD34- and CD45RA-depleted cell fraction. Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Cell composition of G-PBSC before and after CD45RA depletion. Enumeration of cell content of G-PBSC before (circles) and after (squares) CD45RA depletion. (A) Total nucleated cells. (B) CD14+ monocytes. (C) CD3+ CD4+ T cells. (D) CD3+ CD8+ T cells. (E) CD4+ TCM (CD3+CD4+CD45RO+CD45RA−CCR7+ CD27+ CD28+). (F) CD8+ TCM (CD3+CD8+CD45RO+ CD45RA−CCR7+ CD27+CD28+). (G) T regulatory cells (CD3+ CD4+ CD25+ FOXP3+CD45RA+/−). (H) CD45RA+ T regulatory cells (CD3+CD4+CD25+FOXP3+CD45RA+). (I) CD56+CD3− NK cells. (J) CD19+ B cells. *P < .05 (Student paired t test) Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 Virus-specific T cells in G-PBSC before and after CD45RA depletion. (A) Flow cytometry plots showing MHC tetramer staining for viral epitopes (CMV pp65 NLVPMVATV and EBV BMLF1 GLCTLVAML) of CD8+ T cells enriched from G-PBSC and CD45RA-depleted PBSC from a representative HLA-A2+ CMV+ EBV+ donor. (B) Tetramer evaluation of G-PBSC and CD45RA-depleted PBSC from 7 HLA-A2+ CMV+ EBV+ donors. (i) CMV NLV–specific T cells and (ii) EBV GLC–specific T cells as a proportion of CD8+ T cells; CD28 expression on (iii) CMV NLV CD8+ and (iv) EBV GLC CD8+ T cells; CCR7 expression on (v) CMV NLV CD8+ and (vi) EBV GLC CD8+ T cells. Analyzed by Student paired t-test. Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 ELISpot assays evaluating pathogen-specific IFNγ secretion by T cells after peptide stimulation of G-PBSC and CD45RA+-depleted G-PBSC. (A) Representative IFN-γ ELISpot showing response of T cells from G-PBSC and CD45RA-depleted G-PBSC to pp65 and control (NYBR1) peptides. The figure shows 1 of 3 replicate wells for each cell concentration for each condition. (B) IFN-γ ELISpot assay of T cells derived from G-PBSC and CD45RA+-depleted G-PBSC from a CMV+ donor (i) and a CMV− donor (ii) to CMV pp65, CMV IE1, EBV BZLF, EBV EBNA1, EBV LMP2A, or adenovirus 15 mer peptide pools. Shown are the mean and standard deviation of the spot frequency in response to the viral or control peptide stimulation (PBSC + viral peptide = black; PBSC + control = dark grey; CD45RA-depleted PBSC + viral peptide = white; CD45RA-depleted + control = light grey). (C) IFN-γ response in donor PBSC (circles) and corresponding CD45RA-depleted PBSC (triangles): responses to CMV pp65 (i) and IE-1 (ii) peptides in CMV-seropositive donors (upper 5) and CMV-seronegative donors (lower 2), adenovirus (iii), EBV BZLF (iv), EBNA-1 (v), and LMP2A (vi). Responses to control peptide are subtracted from the virus-specific response. Spot frequencies of < 100/100,000 (<.1%) are considered negative. Analyzed by Student paired t-test. Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 7 Intracellular cytokine flow cytometry to evaluate virus-specific T cells derived from PBSC and CD45RA-depleted PBSC. (A) IFNγ and IL2 secretion by CD4+ or CD8+ T cells expanded from G-PBSC or CD45RA+-depleted G-PBSC after restimulation with EBNA1 peptide or moDC alone. (B&C) Frequency of CD4+ and CD8+ T cells from G-PBSC or CD45RA-depleted G-PBSC from representative donors that produce IFNg or both IFNg and IL-2 after restimulation with (B) EBNA-1 and (C) pp65 peptides. The frequency of T cells responding to the negative control is subtracted from the data shown in (B) and (C). Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 8 Lymphoproliferation assays to evaluate CD4+ T cell responses to opportunistic pathogens. (A) Proliferation of CD4+ T cells enriched from G-PBSC (striped) and CD45RA+-depleted G-PBSC (white) from representative CMV+ (left) and CMV− (right) donors after stimulation with protein antigen preparations from dengue (negative control), CMV, adenovirus, HSV, VZV, and influenza A viruses. Shown are the mean and standard deviation. (B) Proliferation of CD4-enriched PBSC (circles) and CD45RA-depleted CD4-enriched PBSC (squares) in response to antigen stimulation with (i) CMV, (ii) ADV, (iii) HSV, (iv) VZV, and (v) influenza. The stimulation index shows proliferation relative to negative control wells. A simulation index < 3 is considered negative. Analyzed by Student paired t-test. Biology of Blood and Marrow Transplantation 2014 20, 705-716DOI: (10.1016/j.bbmt.2014.01.032) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions